Shanghai, China · Founded 2014 · Privately Held (backing)
Provider of cell and gene therapy platform intended to empower the innovative drug development industry. Miaoshun Biotechnology is based in Shanghai, China and was founded in 2014. It has raised $28.2 million.
Last price · $/share
—
Implied valuation
—
Total raised
$28.2M
Last round
—
Cap table — not yet on record
Miaoshun Biotechnology's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Miaoshun Biotechnology with a free account
·Watch Miaoshun Biotechnology: the Monday email on marks, rounds and moves
